Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 15 of 15

Publication Record


Evolution of exenatide as a diabetes therapeutic.
Bhavsar S, Mudaliar S, Cherrington A
(2013) Curr Diabetes Rev 9: 161-93
MeSH Terms: Animals, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Drug Therapy, Combination, Exenatide, Glucagon-Like Peptide 1, Glycated Hemoglobin A, Humans, Hypoglycemic Agents, Metformin, Mice, Mice, Knockout, Models, Animal, Nausea, Peptides, Sulfonylurea Compounds, Thiazolidinediones, Venoms, Weight Loss
Added February 13, 2015
0 Communities
1 Members
0 Resources
21 MeSH Terms
GLP-1 analog attenuates cocaine reward.
Graham DL, Erreger K, Galli A, Stanwood GD
(2013) Mol Psychiatry 18: 961-2
MeSH Terms: Animals, Brain, Cocaine-Related Disorders, Conditioning, Operant, Disease Models, Animal, Dose-Response Relationship, Drug, Exenatide, Exploratory Behavior, Glucagon-Like Peptide 1, Male, Mice, Mice, Inbred C57BL, Peptides, Reward, Venoms
Added February 19, 2015
0 Communities
1 Members
0 Resources
15 MeSH Terms
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.
Niswender K, Pi-Sunyer X, Buse J, Jensen KH, Toft AD, Russell-Jones D, Zinman B
(2013) Diabetes Obes Metab 15: 42-54
MeSH Terms: Blood Glucose, Body Mass Index, Diabetes Mellitus, Type 2, Exenatide, Female, Glucagon-Like Peptide 1, Glycated Hemoglobin A, Humans, Hypoglycemic Agents, Insulin Glargine, Insulin, Long-Acting, Liraglutide, Male, Middle Aged, Peptides, Pyrazines, Sitagliptin Phosphate, Sulfonylurea Compounds, Thiazolidinediones, Triazoles, Venoms, Weight Loss
Added February 15, 2016
0 Communities
1 Members
0 Resources
22 MeSH Terms
Treatment with glucagon-like Peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor.
Simmons JH, Shoemaker AH, Roth CL
(2012) Horm Res Paediatr 78: 54-8
MeSH Terms: Adolescent, Brain Neoplasms, Exenatide, Glucagon-Like Peptide 1, Humans, Hypoglycemic Agents, Hypothalamic Neoplasms, Male, Neoplasms, Germ Cell and Embryonal, Obesity, Peptides, Venoms
Added January 20, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
Exendin-4 decreases amphetamine-induced locomotor activity.
Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A
(2012) Physiol Behav 106: 574-8
MeSH Terms: Amphetamine, Animals, Antimanic Agents, Anxiety, Central Nervous System Stimulants, Conditioning, Operant, Exenatide, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor, Lithium Chloride, Male, Motor Activity, Peptides, Rats, Rats, Sprague-Dawley, Receptors, Glucagon, Venoms
Added September 17, 2013
0 Communities
3 Members
0 Resources
17 MeSH Terms